Even so, our results also suggest that elevated CYP2A6 alone is not sufficient to substitute for p53 activity in limiting liver tumorigenesis, consistent with the diverse repertoire of p53 tumour-suppressive activities in the cell. The gene discussed is TP53; the disease is neoplasm.